Chuck Royce started to build up the position in CVS Health in Q1 2023 and continued to invest until Q3 2024. Since then they sold 87 Thousand shares. The investor completely sold their stake between Q4 2024 and Q1 2025.
Avg closing price
Price range
Sold -38 Thousand shares
Q1 2025
Avg closing price
$59.61
Price range
$44.22
-
$68.64
Sold 56.3% shares (-49 Thousand shares)
Q4 2024
Avg closing price
$55.81
Price range
$43.93
-
$67.46
Increased shares by 2.4% (+2 Thousand shares)
Q3 2024
Avg closing price
$58.30
Price range
$55.81
-
$63.18
Increased shares by 24.1% (+16.5 Thousand shares)
Q2 2024
Avg closing price
$62.55
Price range
$53.63
-
$79.56
Increased shares by 19.1% (+11 Thousand shares)
Q3 2023
Avg closing price
$70.86
Price range
$65.17
-
$76.41
Increased shares by 32.2% (+14 Thousand shares)
Q2 2023